Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
153.67
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
397
Open
153.67
Bid (Size)
153.54 (1)
Ask (Size)
159.09 (1)
Prev. Close
153.67
Today's Range
153.67 - 153.67
52wk Range
134.09 - 175.91
Shares Outstanding
N/A
Dividend Yield
3.38%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
AbbVie Provides Regulatory Update On Parkinson's Disease Drug Candidate
March 22, 2023
AbbVie Inc (NYSE: ABBV) provided a regulatory update on its New Drug Application (NDA) for
Via
Benzinga
Price Over Earnings Overview: AbbVie
March 22, 2023
Via
Benzinga
Performance
YTD
-5.36%
-5.36%
1 Month
+1.10%
+1.10%
3 Month
-5.26%
-5.26%
6 Month
+9.52%
+9.52%
1 Year
-3.96%
-3.96%
More News
Read More
4 Top Value Stock ETFs for Long-Term Wealth Building
March 19, 2023
Via
The Motley Fool
This Is What Whales Are Betting On AbbVie
March 17, 2023
Via
Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
March 16, 2023
Via
Benzinga
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
March 16, 2023
Via
Investor's Business Daily
Is It Too Late to Buy AbbVie Stock?
March 09, 2023
Via
The Motley Fool
2 Top Dividend Kings to Buy for the Long Haul
March 04, 2023
Via
The Motley Fool
2 Growth Stocks to Buy Before the Bull Market Arrives
March 16, 2023
Via
The Motley Fool
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
March 15, 2023
Via
Benzinga
Healthcare Stocks With at Least 30 Years of Dividend Increases
March 14, 2023
Via
MarketBeat
Oracle, AbbVie And This Gold Fund: CNBC's 'Final Trades'
March 14, 2023
Via
Benzinga
Dividend Income Update February 2023
March 14, 2023
Via
Talk Markets
5 Forever Dividend Stocks
March 14, 2023
Via
The Motley Fool
Diversify Your Income with These 2 High-Yielding Dividend ETFs
March 14, 2023
Via
MarketBeat
Topics
ETFs
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
March 13, 2023
Via
Benzinga
3 No-Brainer Dividend Stocks to Buy in March
March 11, 2023
Via
The Motley Fool
Reap Monthly Income With This Combination Of 3 Stocks
March 09, 2023
Via
Talk Markets
3 Surefire Stocks That Are Screaming Buys in March
March 09, 2023
Via
The Motley Fool
3 High-Yield Dividend Stocks to Buy Before the Next Bull Rally
March 09, 2023
Via
The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
Via
Benzinga
How to Pick the Best Dividend Stocks
March 07, 2023
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
The Stock That Tripled in a Day...And May Not Be Done
March 07, 2023
Via
MarketBeat
7 Dividend Kings to Buy for an Uncertain Market Environment
March 06, 2023
Via
InvestorPlace
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
March 06, 2023
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
